Gates Foundation Invests $40 Million in UK Immunotherapy Company Gates Foundation Invests $40 Million in UK Immunotherapy Company

The Bill and Melinda Gates Foundation is to invest up to $40 million in privately held British biotech company Immunocore to support its development of immunotherapies for infectious diseases.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Internal Medicine News Source Type: news